View Press Releases
-
Advarra appoints Brian Hart as Chief Technology Officer
Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research
Aug 3, 2025
-
New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication
New research from the COPD Foundation and Phreesia shows patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life.
Aug 3, 2025
-
InSysBio to launch Immune Response Template Open for QSP modeling
InSysBio announces Immune Response Template (IRT) which was previously available under a license model now is completely free to use. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.
Aug 4, 2025
-
AppOmni Launches New SaaS and AI Security Packages to Tackle Rising Risks
I wanted to share that Software-as-a-Service (SaaS) security leader, AppOmni today announced new innovations to combat rising AI and SaaS risks for healthcare companies: https://appomni.com/press-releases/saas-ai-security-innovation Please let me know if you’d like to speak with them for more about the benefits for healthcare, get a product image, or if I can provide anything further. The rapid adoption of AI has introduced a new and complex attack surface that healthcare cybersecurity teams must manage. AI is an active participant in the SaaS environment; whether embedded in SaaS platforms (such as M365 or Google Workspace) or acting as agents, AI tools constantly access and process sensitive data across the SaaS estate. Healthcare organizations need the ability to identify unsanctioned or shadow AI and SaaS usage, as well as practical strategies to control and monitor AI usage. AppOmni is defining the future of SaaS and AI security by arming organizations of all sizes with the end-to-end controls needed for safe usage of these applications, helping them identify critical risks, protect sensitive data, detect abnormal behavior, and respond to evolving threats. The new features help healthcare understand their risk exposure to AI and implement controls to secure them by identifying both sanctioned and unsanctioned/ shadow AI apps, including AI embedded within SaaS applications. It’s also adding support for 30 new AI and SaaS applications, including ChatGPT Enterprise, Claude, OpenAI, and Anthropic, Cisco Umbrella, Cisco Secure Access, and Gong. And it’s giving healthcare organizations a free 90-day trial of its new AppOmni Foundations package – a SaaS security starter solution for organizations that need to discover shadow SaaS and AI, app users and permission, and detect threats and anomalous activities.
Aug 3, 2025
-
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions
Jul 31, 2025
-
Clearwater Launches New Enterprise Cyber Risk Management Solution to Help Healthcare Organizations Reduce Cyber Risk, Strengthen Compliance, and Drive Boardroom Confidence
Jul 30, 2025
-
Clinisys Acquires Orchard Software
Clinisys announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.
Jul 28, 2025
-
Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product
Jul 30, 2025
-
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
Jul 29, 2025
-
Camgenium Develops App to Improve Outcomes for Prostate Cancer Patients Before and After Surgery
Camgenium today announced its partnership with Professor Petre Cristian Ilie, Consultant Urological and Robotic Surgeon at NNUH NHS Foundation Trust, to develop HealthiumPro, a cloud-based innovative software solution. The system has the potential to improve the outcomes of prostate cancer patients by enhancing safety before and after surgery.
Jul 23, 2025
-
Vidir Solutions Introduces VLM Mini for Healthcare, Pharmaceutical, and Laboratory Storage
Compact Vertical Lift Module Engineered for Low-Height Environments with Intelligent Inventory Control
Jul 29, 2025
-
Association for Molecular Pathology Announces 2025 Award Recipients
AMP announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards.
Jul 27, 2025
-
Clearwater Strengthens Cyber Defense in Healthcare and the Defense Industrial Base with Enhanced Threat Intelligence from Google Cloud
Jul 23, 2025
-
Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment
Jul 24, 2025
-
START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials
START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.
Jul 23, 2025
-
Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test
Jul 22, 2025
-
Appointment; Abzena Appoints Geoffrey M. Glass as Chief Executive Officer
Jul 22, 2025
-
Zymo Research and the Institute for Genome Sciences at the University of Maryland School of Medicine Partner to Host a BioFestival Supporting Scientific Innovation and Academic Research
I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing our partnership with the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine to co-host the BioFestival on October 17, 2025. This event is designed to support emerging scientists, promote interdisciplinary collaboration, and foster disruptive innovation in the life sciences. The BioFestival will feature interactive science booths, professional networking, and the BioDisruptor Grant Competition, where students will compete for over $9,000 in cash prizes and $20,000 in Zymo Research product credits and services. We believe this event will be of significant interest to your readers, especially those focused on life sciences, academic research, biotechnology innovation, and student-driven discovery. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/university-of-maryland-biofestival
Jul 21, 2025
-
Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025
Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025
Jul 21, 2025
-
Zymo Research Sets New Standard in NGS Library Prep with Endura™ Tn5 Transposase
I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the launch of Endura™ Tn5 Transposase, a next-generation solution for NGS library preparation workflows. Endura™ Tn5 is specifically engineered for enhanced stability and consistent performance in NGS-based applications. This innovation addresses long-standing challenges in Tn5 technologies, including enzyme instability and variability in fragmentation results. We believe this launch will be of significant interest to your readers in genomics, molecular biology, sequencing technologies, and life science research. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/zymo-research-endura-tn5-transposase We would greatly appreciate it if you would consider sharing this news with your readers. If you require any additional information, high-resolution images, or would like to arrange an interview with one of our experts, please do not hesitate to reach out. I look forward to the opportunity to collaborate with your team. Thank you for your time and consideration.
Jul 20, 2025


